Certain Maternal Antibodies in Relation to Doppler in Hypertension With Pregnancy
NCT ID: NCT03214393
Last Updated: 2017-07-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2017-08-01
2018-08-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pulmonary Artery Doppler And Neonatal Outcome In Hypertensive Disorders Of Pregnancy
NCT05793125
Vascular Endothelial Factor Gene Polymorphism in Preeclampsia
NCT03500588
Placental Protein 13 Serum Endoglin and Uterine Doppler Indeces as Predictors of Pre-eclampsia
NCT02350036
Combined 3D Power Doppler Placental Volume and Vascular Flow Indices In the First Trimester of Pregnancy as Predictors Of Preeclampsia?.
NCT03399006
Fetal Renal Artery Doppler in Patients With Preeclampsia
NCT06395974
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pre-Eclampsia
pregnant women with Pre-Eclampsia will be assessed by serum antibodies and Doppler
Doppler
Doppler will be done to pregnant women with Pre-Eclampsia
serum antibodies
serum antibodies will be measured for pregnant women with Pre-Eclampsia
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Doppler
Doppler will be done to pregnant women with Pre-Eclampsia
serum antibodies
serum antibodies will be measured for pregnant women with Pre-Eclampsia
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Pre-eclampsia
* Singleton pregnancy
Exclusion Criteria
* Fetus with apparent congenital anomalies
* Pregnant females with other medical disorders
* History of essential hypertension.
* History of antepartum hemorrhage.
* History of rupture of membranes.
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Doaa Shafie Belal
Principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Doaa Sh Belal, MD
Role: PRINCIPAL_INVESTIGATOR
Cairo U
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Obstetrics and Gynecology
Cairo, Greater Cairo, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
3650
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.